Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct;29(10):1169-1172.
doi: 10.18553/jmcp.2023.29.10.1169.

Resmetirom for nonalcoholic steatohepatitis

Shahariar Mohammed Fahim  1 , Jeffrey A Tice  2 , Kangho Suh  3 , Josh J Carlson  4 , Marina Richardson  1 , Janet N Chu  2 , Belen Herce-Hagiwara  1 , Foluso Agboola  1 , David Rind  1 , Steven D Pearson  1
Affiliations

Resmetirom for nonalcoholic steatohepatitis

Shahariar Mohammed Fahim et al. J Manag Care Spec Pharm. 2023 Oct.
No abstract available

PubMed Disclaimer

References

    1. Younossi Z, Henry L. Contribution of alcoholic and nonalcoholic fatty liver disease to the burden of liver-related morbidity and mortality. Gastroenterology. 2016;150(8):1778-85. doi:10.1053/j.gastro.2016.03.005 - PubMed
    1. Han MA, Altayar O, Hamdeh S, et al. . Rates of and factors associated with placebo response in trials of pharmacotherapies for nonalcoholic steatohepatitis: Systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2019;17(4):616-2.e626. doi:10.1016/h.cgh.2018.06.011 - PubMed
    1. Younossi Z, Ratziu V, Loomba R, et al. . GS-06-positive results from REGENERATE: A phase 3 international, randomized, placebo-controlled study evaluating obeticholic acid treatment for NASH. J Hepatol. 2019;70(1):e5. doi:10.1016/S0618-8278(19)30006-4
    1. Singh S, Allen AM, Wang Z, Prokop LJ, Murad MH, Loomba R. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: A systematic review and meta-analysis of paired-biopsy studies. Clin Gastroenterol Hepatol. 2015;13(4):643-54.e641-649; quiz e639-40. doi:10.1016/j.cgh.2014.04.014 - PMC - PubMed
    1. Chalasani N, Younossi Z, Lavine JE, et al. . The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328-57. doi:10.1002/hep.29367 - PubMed

LinkOut - more resources